These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3929873)

  • 1. Effect of isosorbide dinitrate, verapamil, and labetalol on portal pressure in cirrhosis.
    Freeman JG; Barton JR; Record CO
    Br Med J (Clin Res Ed); 1985 Aug; 291(6495):561-2. PubMed ID: 3929873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of peroral administration of isosorbide dinitrate on portal pressure and blood flow in patients with cirrhosis of the liver.
    Cervinka J; Kordac V; Kalab M
    J Int Med Res; 1989; 17(6):560-4. PubMed ID: 2628133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of portal hypertension with isosorbide dinitrate alone and in combination with vasopressin.
    Hallemans R; Naeije R; Mols P; Mélot C; Reding P
    Crit Care Med; 1983 Jul; 11(7):536-40. PubMed ID: 6861502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of isosorbide-5-mononitrate on variceal pressure and systemic and splanchnic haemodynamics in patients with cirrhosis.
    Escorsell A; Feu F; Bordas JM; García-Pagán JC; Luca A; Bosch J; Rodés J
    J Hepatol; 1996 Apr; 24(4):423-9. PubMed ID: 8738728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of sublingual isosorbide dinitrate on wedged hepatic venous pressure in cirrhotics with portal hypertension.
    Qureshi H; Zuberi SJ; Faruqui A
    Indian J Gastroenterol; 1988 Jul; 7(3):161-2. PubMed ID: 3397139
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of isosorbide dinitrate on portal hypertension in alcoholic cirrhosis.
    Merkel C; Finucci G; Zuin R; Bazzerla G; Bolognesi M; Sacerdoti D; Gatta A
    J Hepatol; 1987 Apr; 4(2):174-80. PubMed ID: 3584925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic and regional hemodynamic effects of isosorbide dinitrate in patients with liver cirrhosis and portal hypertension.
    Mols P; Hallemans R; Melot C; Lejeune P; Naeije R
    J Hepatol; 1989 May; 8(3):316-24. PubMed ID: 2732445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis. Effects on splanchnic and systemic hemodynamics and liver function.
    Navasa M; Chesta J; Bosch J; Rodés J
    Gastroenterology; 1989 Apr; 96(4):1110-8. PubMed ID: 2925055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hemodynamic effect of verapamil on portal hypertension in patients with postnecrotic cirrhosis.
    Kong CW; Lay CS; Tsai YT; Yeh CL; Lai KH; Lee SD; Lo KJ; Chiang BN
    Hepatology; 1986; 6(3):423-6. PubMed ID: 3710430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic effects of combined treatment with somatostatin analogue (SMS 201-995) and low-dose isosorbide dinitrate on portal hypertension in conscious cirrhotic rats.
    Hori N; Okanoue T; Sawa Y; Itoh Y; Mori T; Takami S; Kashima K
    J Gastroenterol; 1994 Aug; 29(4):460-8. PubMed ID: 7951857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term haemodynamic effects of isosorbide 5-mononitrate in patients with cirrhosis and portal hypertension.
    García-Pagán JC; Feu F; Navasa M; Bru C; Ruiz del Arbol L; Bosch J; Rodés J
    J Hepatol; 1990 Sep; 11(2):189-95. PubMed ID: 2123914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect and mechanism of action of isosorbide-5-mononitrate.
    Hayes PC; Westaby D; Williams R
    Gut; 1988 Jun; 29(6):752-5. PubMed ID: 3384359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The acute and chronic effects of isosorbide-5-mononitrate on portal haemodynamics in cirrhosis.
    Grose RD; Plevris JN; Redhead DN; Bouchier IA; Hayes PC
    J Hepatol; 1994 Apr; 20(4):542-7. PubMed ID: 8051395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of action of isosorbide-5-mononitrate in reducing portal pressure in cirrhotic patients with cirrhosis and portal hypertension.
    Jenkins SA; Shields R
    J Gastroenterol Hepatol; 1991; 6(1):91-3. PubMed ID: 1883984
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute administration of carvedilol is more effective than propranolol plus isosorbide-5-mononitrate in the reduction of portal pressure in patients with viral cirrhosis.
    Lin HC; Yang YY; Hou MC; Huang YT; Lee FY; Lee SD
    Am J Gastroenterol; 2004 Oct; 99(10):1953-8. PubMed ID: 15447755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study.
    García-Pagán JC; Feu F; Bosch J; Rodés J
    Ann Intern Med; 1991 May; 114(10):869-73. PubMed ID: 2014947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis.
    Garcia-Pagán JC; Navasa M; Bosch J; Bru C; Pizcueta P; Rodés J
    Hepatology; 1990 Feb; 11(2):230-8. PubMed ID: 2307401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Propranolol and 5-isosorbide mononitrate in patients with cirrhosis: systemic and portal hemodynamic events].
    Castaño G; Viudez P; Sookoian S; Carlevaro O; Riccitelli M; Frider B
    Gastroenterol Hepatol; 2000; 23(6):275-81. PubMed ID: 15324622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doppler sonography and hepatic vein catheterization in portal hypertension: assessment of agreement in evaluating severity and response to treatment.
    Merkel C; Sacerdoti D; Bolognesi M; Bombonato G; Gatta A
    J Hepatol; 1998 Apr; 28(4):622-30. PubMed ID: 9566831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of peroral administration of isosorbide dinitrate on portal pressure and flow in patients with liver cirrhosis].
    Cervinka J; Kaláb M; Munclinger M; Kordac V; Tesar V; Marecek Z; Petrtýl J; Perlík F; Brodanová M; Ort J
    Cas Lek Cesk; 1988 Jan; 127(5):140-3. PubMed ID: 3356031
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.